Hurts Likely to Miss Season After Blood Clots

Philadelphia Eagles quarterback Jalen Hurts has deep vein thrombosis and bilateral pulmonary emboli, the team and agent Nicole Lynn said Oct. 19, 2026. He is clinically stable with no significant functional limitations, on blood thinners that bar contact play, and expected to make a full recovery with no long-term effects. ESPN reported he is expected to miss the rest of the 2026 season, with treatment lasting at least three months and a possible return by mid-January 2027. The Eagles have not announced an official timeline. The issue began with a cleat to the calf Oct. 4 against the Rams. Hurts told the team Oct. 8. After flying to London Oct. 9, an Oct. 10 ultrasound found left calf superficial vein thrombosis. Doctors told him not to sleep as a precaution. He started the Oct. 11 Jaguars game after roughly 36 hours awake, throwing for 220 yards and a touchdown in a 19-17 loss, Tom Pelissero reported. Further U.S. testing showed clot movement; he went on injured reserve around Oct. 17-18 after tests indicated clots in the lungs. Left-rated coverage has stressed questions about the team's medical decisions; right-rated coverage has led with the season-out diagnosis.